HIGHLIGHTS
- who: David B. DeLurgio MD from the (UNIVERSITY) have published the research work: Hybrid Epicardial-Endocardial Ablation for Long-Standing Persistent Atrial Fibrillation: A Subanalysis of the CONVERGE Trial, in the Journal: (JOURNAL)
- what: To explore the impact of hybrid convergent ablation on LSPAF, for which there is a lack of effective treatments, the authors performed a post hoc analysis of the CONVERGE trial focused on the LSPAF subpopulation. One procedural difference in this study compared with the CONVERGE trial was that the hybrid convergent procedure was staged with epicardial catheter ablation performed 6 weeks . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.